We believe that care for inflammatory bowel disease (IBD) needs significant improvement. Despite advancements in medicine and science, the journey of those living with IBD remains unpredictable, affecting the quality of life for many individuals.
We are proud to highlight the role of intestinal ultrasound as a groundbreaking, non-invasive tool that is transforming the management of IBD. This advanced technology is making a positive impact on patients' lives, providing better insights and enhancing treatment options.
Intestinal Ultrasound (IUS) is a non-invasive imaging technique used to visualize the intestines and surrounding structures in real-time. It is particularly valuable in diagnosing and monitoring inflammatory bowel diseases like Crohn's disease and ulcerative colitis, offering a radiation-free alternative to other imaging methods.
Be part of a growing network dedicated to the advancement of intestinal ultrasound. Work with us to develop educational programs, research initiatives, and clinical practices that set new standards in IBD.
PARTNER WITH US
Dr. Michael Dolinger is a pediatric gastroenterologist and IBD specialist focused on improving outcomes through IUS. An expert in IUS, he leads global education initiatives and his research highlights its role in enhancing IBD trials and treatment, especially for children and pregnant women.
Dr. Michael Dolinger is a pediatric gastroenterologist and IBD specialist focused on improving outcomes through IUS. An expert in IUS, he leads global education initiatives and his research highlights its role in enhancing IBD trials and treatment, especially for children and pregnant women.
Dr. Noa Krugliak Cleveland is a gastroenterologist and IBD specialist. As Director of the IUS Program at the University of Chicago, she trains North American clinicians in iUS. A global leader in IUS education, her work advances the use of ultrasound in IBD care, improving outcomes across North America and beyond.
Dr. Noa Krugliak Cleveland is a gastroenterologist and IBD specialist. As Director of the IUS Program at the University of Chicago, she trains North American clinicians in iUS. A global leader in IUS education, her work advances the use of ultrasound in IBD care, improving outcomes across North America and beyond.
Dr. David T. Rubin, a world-renowned gastroenterologist and IBD expert, has advanced IBD treatment through his clinical practice and research. As Senior Advisor at iUSCAN, he leads a Helmsley-funded program promoting IUS adoption in North America. He has authored 500+ papers, including the ACG Guidelines for Ulcerative Colitis.
Dr. David T. Rubin, a world-renowned gastroenterologist and IBD expert, has advanced IBD treatment through his clinical practice and research. As Senior Advisor at iUSCAN, he leads a Helmsley-funded program promoting IUS adoption in North America. He has authored 500+ papers, including the ACG Guidelines for Ulcerative Colitis.
Dr. Kerri Novak, a gastroenterologist and IBD specialist, pioneered the use of IUS in Canada after training in Germany. She founded Canada’s first IBD clinic offering routine IUS and developed a research program on its impact. Her efforts made the University of Calgary a global training hub for IUS.
Dr. Kerri Novak, a gastroenterologist and IBD specialist, pioneered the use of IUS in Canada after training in Germany. She founded Canada’s first IBD clinic offering routine IUS and developed a research program on its impact. Her efforts made the University of Calgary a global training hub for IUS.
The first gastroenterologists in the United States undergo intestinal ultrasound (IUS) training via the International Bowel Ultrasound Group (IBUS) curriculum.
The first IBUS module 1 hands-on training in the United States occurs at the Icahn School of Medicine at Mount Sinai, introducing IUS to 36 new centers in the United States and Canada, increasing interest and demand among both gastroenterologists and patients.
Dr. David Rubin and the University of Chicago receive a 3-year grant from the Leona M. and Harry B. Helmsley Charitable Trust to expand IUS in North America, forming a research alliance with IBUS, Mount Sinai, and the University of Calgary. iUSCAN was founded to meet growing demand, focusing on IUS education, training, research and advocacy in IBD care.
As the initial grant funding from the Helmsley Charitable Trust comes to an end, iUSCAN is established as an official non-profit organization, allowing the organization to grow independently to continue to meet the IUS needs of North America.
